Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies

by Adriano R. Tonelli, Sandeep Sahay, Kathryn W. Gordon, Lisa D. Edwards, Andrew G. Allmon, Meredith Broderick, Andrew C. Nelsen
Published 2020-12-01

A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil

by Diane L. Zwicke, Ricardo Restrepo-Jaramillo, Hassan Alnuaimat, Kathryn Gordon, Meredith Broderick, Lisa D. Edwards, Andrew Allmon, Peter J. Leary
Published 2021-03-01

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.

by Alvar Agustí, Lisa D Edwards, Stephen I Rennard, William MacNee, Ruth Tal-Singer, Bruce E Miller, Jørgen Vestbo, David A Lomas, Peter M A Calverley, Emiel Wouters, Courtney Crim, Julie C Yates, Edwin K Silverman, Harvey O Coxson, Per Bakke, Ruth J Mayer, Bartolome Celli, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Published 2012-01-01